nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLC22A11—Methotrexate—germ cell cancer	0.102	0.189	CbGbCtD
Bumetanide—SLC22A7—Methotrexate—germ cell cancer	0.0972	0.181	CbGbCtD
Bumetanide—PTGS2—Cisplatin—germ cell cancer	0.086	0.16	CbGbCtD
Bumetanide—PTGS2—Etoposide—germ cell cancer	0.0845	0.157	CbGbCtD
Bumetanide—SLCO1A2—Methotrexate—germ cell cancer	0.0682	0.127	CbGbCtD
Bumetanide—SLC22A8—Methotrexate—germ cell cancer	0.0594	0.11	CbGbCtD
Bumetanide—SLC22A6—Methotrexate—germ cell cancer	0.0413	0.0768	CbGbCtD
Bumetanide—Serum amylase increased—Cisplatin—germ cell cancer	0.0175	0.104	CcSEcCtD
Bumetanide—Asterixis—Ifosfamide—germ cell cancer	0.0157	0.0938	CcSEcCtD
Bumetanide—SLC22A8—choroid plexus—germ cell cancer	0.013	0.0573	CbGeAlD
Bumetanide—SLC12A5—ganglion—germ cell cancer	0.00847	0.0375	CbGeAlD
Bumetanide—SLC12A1—urine—germ cell cancer	0.00597	0.0264	CbGeAlD
Bumetanide—Diuresis—Cisplatin—germ cell cancer	0.00592	0.0353	CcSEcCtD
Bumetanide—SLC12A1—appendage—germ cell cancer	0.00582	0.0257	CbGeAlD
Bumetanide—SLC22A8—optic choroid—germ cell cancer	0.00497	0.022	CbGeAlD
Bumetanide—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00493	0.073	CbGpPWpGaD
Bumetanide—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00447	0.0663	CbGpPWpGaD
Bumetanide—SLC12A1—ganglion—germ cell cancer	0.00407	0.018	CbGeAlD
Bumetanide—Amylase increased—Cisplatin—germ cell cancer	0.00385	0.023	CcSEcCtD
Bumetanide—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00376	0.0557	CbGpPWpGaD
Bumetanide—SLC12A5—brainstem—germ cell cancer	0.00368	0.0163	CbGeAlD
Bumetanide—SLC12A5—eye—germ cell cancer	0.00359	0.0159	CbGeAlD
Bumetanide—SLC12A5—retina—germ cell cancer	0.00355	0.0157	CbGeAlD
Bumetanide—SLC22A8—urine—germ cell cancer	0.00347	0.0153	CbGeAlD
Bumetanide—Serum creatinine increased—Ifosfamide—germ cell cancer	0.00346	0.0206	CcSEcCtD
Bumetanide—SLC12A4—embryo—germ cell cancer	0.00334	0.0148	CbGeAlD
Bumetanide—SLC12A5—telencephalon—germ cell cancer	0.00327	0.0145	CbGeAlD
Bumetanide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00314	0.0465	CbGpPWpGaD
Bumetanide—SLC12A4—brainstem—germ cell cancer	0.00306	0.0135	CbGeAlD
Bumetanide—Serum creatinine increased—Cisplatin—germ cell cancer	0.00298	0.0178	CcSEcCtD
Bumetanide—SLC12A4—eye—germ cell cancer	0.00298	0.0132	CbGeAlD
Bumetanide—SLC12A4—retina—germ cell cancer	0.00295	0.013	CbGeAlD
Bumetanide—Cholestasis—Ifosfamide—germ cell cancer	0.0028	0.0167	CcSEcCtD
Bumetanide—SLC12A4—telencephalon—germ cell cancer	0.00271	0.012	CbGeAlD
Bumetanide—SLC12A5—pituitary gland—germ cell cancer	0.00266	0.0118	CbGeAlD
Bumetanide—SLC12A5—medulla oblongata—germ cell cancer	0.00257	0.0114	CbGeAlD
Bumetanide—SLC12A2—trigeminal ganglion—germ cell cancer	0.00239	0.0105	CbGeAlD
Bumetanide—SLC12A5—midbrain—germ cell cancer	0.00235	0.0104	CbGeAlD
Bumetanide—SLC12A5—spinal cord—germ cell cancer	0.00229	0.0101	CbGeAlD
Bumetanide—SLC12A4—gonad—germ cell cancer	0.00227	0.01	CbGeAlD
Bumetanide—SLC12A4—uterus—germ cell cancer	0.00225	0.00995	CbGeAlD
Bumetanide—Hearing impaired—Ifosfamide—germ cell cancer	0.00224	0.0133	CcSEcCtD
Bumetanide—CA4—ganglion—germ cell cancer	0.00219	0.00968	CbGeAlD
Bumetanide—Liver injury—Cisplatin—germ cell cancer	0.00218	0.013	CcSEcCtD
Bumetanide—SLC12A2—brainstem—germ cell cancer	0.00211	0.00933	CbGeAlD
Bumetanide—SLC12A5—endocrine gland—germ cell cancer	0.00206	0.00912	CbGeAlD
Bumetanide—SLC12A2—eye—germ cell cancer	0.00205	0.00909	CbGeAlD
Bumetanide—SLC12A5—head—germ cell cancer	0.00204	0.009	CbGeAlD
Bumetanide—CA5A—endocrine gland—germ cell cancer	0.00199	0.0088	CbGeAlD
Bumetanide—Hyperuricaemia—Cisplatin—germ cell cancer	0.00198	0.0118	CcSEcCtD
Bumetanide—SLC12A4—adrenal gland—germ cell cancer	0.00197	0.00873	CbGeAlD
Bumetanide—SLC12A5—testis—germ cell cancer	0.00197	0.00869	CbGeAlD
Bumetanide—SLC12A4—midbrain—germ cell cancer	0.00195	0.00862	CbGeAlD
Bumetanide—Hearing impaired—Cisplatin—germ cell cancer	0.00193	0.0115	CcSEcCtD
Bumetanide—PTGS2—appendage—germ cell cancer	0.00191	0.00847	CbGeAlD
Bumetanide—SLC12A4—spinal cord—germ cell cancer	0.0019	0.00841	CbGeAlD
Bumetanide—Azotaemia—Methotrexate—germ cell cancer	0.00189	0.0113	CcSEcCtD
Bumetanide—SLC12A2—telencephalon—germ cell cancer	0.00187	0.00828	CbGeAlD
Bumetanide—Blood uric acid increased—Cisplatin—germ cell cancer	0.00187	0.0111	CcSEcCtD
Bumetanide—SLC12A4—female gonad—germ cell cancer	0.00184	0.00814	CbGeAlD
Bumetanide—Hepatocellular injury—Cisplatin—germ cell cancer	0.00184	0.0109	CcSEcCtD
Bumetanide—SLC12A5—cerebellum—germ cell cancer	0.00182	0.00803	CbGeAlD
Bumetanide—Hyperuricaemia—Etoposide—germ cell cancer	0.00181	0.0108	CcSEcCtD
Bumetanide—SLCO1A2—Transport of organic anions—AVP—germ cell cancer	0.00179	0.0265	CbGpPWpGaD
Bumetanide—SLC12A2—decidua—germ cell cancer	0.00178	0.00785	CbGeAlD
Bumetanide—Polyuria—Ifosfamide—germ cell cancer	0.00176	0.0105	CcSEcCtD
Bumetanide—CA14—telencephalon—germ cell cancer	0.00175	0.00774	CbGeAlD
Bumetanide—SLC12A4—endocrine gland—germ cell cancer	0.00171	0.00757	CbGeAlD
Bumetanide—Blood uric acid increased—Etoposide—germ cell cancer	0.00171	0.0102	CcSEcCtD
Bumetanide—SLC12A4—head—germ cell cancer	0.00169	0.00747	CbGeAlD
Bumetanide—SLC12A4—testis—germ cell cancer	0.00163	0.00722	CbGeAlD
Bumetanide—PTGS2—skin epidermis—germ cell cancer	0.00159	0.00704	CbGeAlD
Bumetanide—SLC12A1—telencephalon—germ cell cancer	0.00157	0.00694	CbGeAlD
Bumetanide—Encephalopathy—Methotrexate—germ cell cancer	0.00157	0.00935	CcSEcCtD
Bumetanide—SLC12A2—gonad—germ cell cancer	0.00156	0.00691	CbGeAlD
Bumetanide—SLC12A2—pituitary gland—germ cell cancer	0.00153	0.00674	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.00152	0.00905	CcSEcCtD
Bumetanide—Polyuria—Cisplatin—germ cell cancer	0.00152	0.00904	CcSEcCtD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00151	0.0224	CbGpPWpGaD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00151	0.0224	CbGpPWpGaD
Bumetanide—SLC12A4—cerebellum—germ cell cancer	0.00151	0.00667	CbGeAlD
Bumetanide—CA7—midbrain—germ cell cancer	0.00151	0.00667	CbGeAlD
Bumetanide—CA12—eye—germ cell cancer	0.0015	0.00662	CbGeAlD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00149	0.022	CbGpPWpGaD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00149	0.022	CbGpPWpGaD
Bumetanide—SLC10A1—gonad—germ cell cancer	0.00148	0.00653	CbGeAlD
Bumetanide—SLC12A5—brain—germ cell cancer	0.00147	0.00652	CbGeAlD
Bumetanide—SLC12A2—medulla oblongata—germ cell cancer	0.00147	0.00651	CbGeAlD
Bumetanide—Blood creatinine increased—Ifosfamide—germ cell cancer	0.00145	0.00863	CcSEcCtD
Bumetanide—CFTR—female gonad—germ cell cancer	0.00145	0.00639	CbGeAlD
Bumetanide—Hypokalaemia—Ifosfamide—germ cell cancer	0.00141	0.00838	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.00139	0.0083	CcSEcCtD
Bumetanide—CA14—medulla oblongata—germ cell cancer	0.00137	0.00608	CbGeAlD
Bumetanide—CA12—telencephalon—germ cell cancer	0.00136	0.00603	CbGeAlD
Bumetanide—SLC12A2—adrenal gland—germ cell cancer	0.00136	0.00602	CbGeAlD
Bumetanide—SLC12A2—midbrain—germ cell cancer	0.00135	0.00595	CbGeAlD
Bumetanide—CFTR—endocrine gland—germ cell cancer	0.00135	0.00595	CbGeAlD
Bumetanide—Hyponatraemia—Cisplatin—germ cell cancer	0.00134	0.00797	CcSEcCtD
Bumetanide—CFTR—head—germ cell cancer	0.00133	0.00587	CbGeAlD
Bumetanide—SLC12A2—bone marrow—germ cell cancer	0.00132	0.00583	CbGeAlD
Bumetanide—SLC12A2—spinal cord—germ cell cancer	0.00131	0.0058	CbGeAlD
Bumetanide—Pancreatitis—Ifosfamide—germ cell cancer	0.00131	0.00781	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00129	0.00768	CcSEcCtD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00128	0.019	CbGpPWpGaD
Bumetanide—CFTR—testis—germ cell cancer	0.00128	0.00567	CbGeAlD
Bumetanide—CA14—adrenal gland—germ cell cancer	0.00127	0.00563	CbGeAlD
Bumetanide—SLC12A2—female gonad—germ cell cancer	0.00127	0.00562	CbGeAlD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00126	0.0187	CbGpPWpGaD
Bumetanide—CA14—midbrain—germ cell cancer	0.00126	0.00555	CbGeAlD
Bumetanide—Blood creatinine increased—Cisplatin—germ cell cancer	0.00125	0.00744	CcSEcCtD
Bumetanide—CA4—neck—germ cell cancer	0.00125	0.00551	CbGeAlD
Bumetanide—Dehydration—Cisplatin—germ cell cancer	0.00124	0.00739	CcSEcCtD
Bumetanide—CA14—spinal cord—germ cell cancer	0.00123	0.00542	CbGeAlD
Bumetanide—SLC12A4—brain—germ cell cancer	0.00122	0.00542	CbGeAlD
Bumetanide—Hypokalaemia—Cisplatin—germ cell cancer	0.00121	0.00723	CcSEcCtD
Bumetanide—Hyperglycaemia—Ifosfamide—germ cell cancer	0.0012	0.00718	CcSEcCtD
Bumetanide—Cramp muscle—Cisplatin—germ cell cancer	0.0012	0.00715	CcSEcCtD
Bumetanide—SLC12A4—lymph node—germ cell cancer	0.00118	0.00523	CbGeAlD
Bumetanide—SLC12A2—endocrine gland—germ cell cancer	0.00118	0.00522	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00118	0.00704	CcSEcCtD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00117	0.0174	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00117	0.0174	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00117	0.0174	CbGpPWpGaD
Bumetanide—Renal failure—Ifosfamide—germ cell cancer	0.00117	0.00698	CcSEcCtD
Bumetanide—CA7—cerebellum—germ cell cancer	0.00117	0.00516	CbGeAlD
Bumetanide—SLC12A2—head—germ cell cancer	0.00117	0.00516	CbGeAlD
Bumetanide—CA9—endocrine gland—germ cell cancer	0.00116	0.00514	CbGeAlD
Bumetanide—SLC22A8—trigeminal ganglion—germ cell cancer	0.00116	0.00513	CbGeAlD
Bumetanide—Vertigo—Vinblastine—germ cell cancer	0.00116	0.00691	CcSEcCtD
Bumetanide—PTGS2—endothelium—germ cell cancer	0.00116	0.00511	CbGeAlD
Bumetanide—Leukopenia—Vinblastine—germ cell cancer	0.00115	0.00688	CcSEcCtD
Bumetanide—CA9—Cellular responses to stress—PHC1—germ cell cancer	0.00113	0.0168	CbGpPWpGaD
Bumetanide—Pancreatitis—Cisplatin—germ cell cancer	0.00113	0.00673	CcSEcCtD
Bumetanide—SLC12A2—testis—germ cell cancer	0.00113	0.00498	CbGeAlD
Bumetanide—SLC10A1—endocrine gland—germ cell cancer	0.00112	0.00494	CbGeAlD
Bumetanide—CA9—testis—germ cell cancer	0.00111	0.00491	CbGeAlD
Bumetanide—Abdominal discomfort—Cisplatin—germ cell cancer	0.0011	0.00658	CcSEcCtD
Bumetanide—Erythema multiforme—Dactinomycin—germ cell cancer	0.0011	0.00658	CcSEcCtD
Bumetanide—SLC10A1—head—germ cell cancer	0.0011	0.00487	CbGeAlD
Bumetanide—SLC12A1—spinal cord—germ cell cancer	0.0011	0.00487	CbGeAlD
Bumetanide—Cramp muscle—Etoposide—germ cell cancer	0.0011	0.00655	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.0011	0.00655	CcSEcCtD
Bumetanide—Hyperuricaemia—Methotrexate—germ cell cancer	0.00109	0.00647	CcSEcCtD
Bumetanide—PTGS2—blood vessel—germ cell cancer	0.00107	0.00471	CbGeAlD
Bumetanide—SLC10A1—testis—germ cell cancer	0.00106	0.00471	CbGeAlD
Bumetanide—SLC12A2—cerebellum—germ cell cancer	0.00104	0.0046	CbGeAlD
Bumetanide—Thrombocytopenia—Vinblastine—germ cell cancer	0.00103	0.00614	CcSEcCtD
Bumetanide—Blood uric acid increased—Methotrexate—germ cell cancer	0.00103	0.00611	CcSEcCtD
Bumetanide—CA9—cerebellum—germ cell cancer	0.00102	0.00453	CbGeAlD
Bumetanide—CA5B—gonad—germ cell cancer	0.00102	0.00452	CbGeAlD
Bumetanide—SLC22A11—endocrine gland—germ cell cancer	0.00102	0.00451	CbGeAlD
Bumetanide—Erythema multiforme—Ifosfamide—germ cell cancer	0.00101	0.00603	CcSEcCtD
Bumetanide—Renal failure—Cisplatin—germ cell cancer	0.00101	0.00602	CcSEcCtD
Bumetanide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.001	0.0149	CbGpPWpGaD
Bumetanide—SLC22A8—eye—germ cell cancer	0.001	0.00442	CbGeAlD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000997	0.0148	CbGpPWpGaD
Bumetanide—SLC22A7—endocrine gland—germ cell cancer	0.000995	0.0044	CbGeAlD
Bumetanide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000988	0.0146	CbGpPWpGaD
Bumetanide—SLC12A1—head—germ cell cancer	0.000978	0.00432	CbGeAlD
Bumetanide—Leukopenia—Bleomycin—germ cell cancer	0.000975	0.00581	CcSEcCtD
Bumetanide—CA14—cerebellum—germ cell cancer	0.000972	0.0043	CbGeAlD
Bumetanide—CFTR—brain—germ cell cancer	0.000962	0.00425	CbGeAlD
Bumetanide—SLCO1A2—telencephalon—germ cell cancer	0.000955	0.00422	CbGeAlD
Bumetanide—CA4—brainstem—germ cell cancer	0.000952	0.00421	CbGeAlD
Bumetanide—SLC22A7—testis—germ cell cancer	0.000949	0.0042	CbGeAlD
Bumetanide—CA7—brain—germ cell cancer	0.000948	0.00419	CbGeAlD
Bumetanide—SLC12A1—testis—germ cell cancer	0.000945	0.00418	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000932	0.00556	CcSEcCtD
Bumetanide—Chest pain—Bleomycin—germ cell cancer	0.000927	0.00553	CcSEcCtD
Bumetanide—Renal failure—Etoposide—germ cell cancer	0.000924	0.00551	CcSEcCtD
Bumetanide—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00091	0.0135	CbGpPWpGaD
Bumetanide—Leukopenia—Dactinomycin—germ cell cancer	0.000909	0.00542	CcSEcCtD
Bumetanide—Gynaecomastia—Methotrexate—germ cell cancer	0.000901	0.00537	CcSEcCtD
Bumetanide—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000896	0.0133	CbGpPWpGaD
Bumetanide—CA5B—adrenal gland—germ cell cancer	0.00089	0.00394	CbGeAlD
Bumetanide—Thrombocytopenia—Bleomycin—germ cell cancer	0.00087	0.00519	CcSEcCtD
Bumetanide—CA12—endocrine gland—germ cell cancer	0.00086	0.0038	CbGeAlD
Bumetanide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00086	0.00513	CcSEcCtD
Bumetanide—CA12—head—germ cell cancer	0.000849	0.00376	CbGeAlD
Bumetanide—SLC12A2—brain—germ cell cancer	0.000845	0.00374	CbGeAlD
Bumetanide—CA4—telencephalon—germ cell cancer	0.000845	0.00374	CbGeAlD
Bumetanide—Vertigo—Ifosfamide—germ cell cancer	0.000836	0.00498	CcSEcCtD
Bumetanide—Leukopenia—Ifosfamide—germ cell cancer	0.000833	0.00497	CcSEcCtD
Bumetanide—Polyuria—Methotrexate—germ cell cancer	0.000832	0.00496	CcSEcCtD
Bumetanide—Abdominal pain—Vinblastine—germ cell cancer	0.000832	0.00496	CcSEcCtD
Bumetanide—Hypotension—Bleomycin—germ cell cancer	0.00083	0.00495	CcSEcCtD
Bumetanide—SLC12A2—lymph node—germ cell cancer	0.000817	0.00361	CbGeAlD
Bumetanide—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000811	0.00484	CcSEcCtD
Bumetanide—SLC10A1—brain—germ cell cancer	0.000799	0.00353	CbGeAlD
Bumetanide—Erythema multiforme—Etoposide—germ cell cancer	0.000798	0.00476	CcSEcCtD
Bumetanide—Chest pain—Ifosfamide—germ cell cancer	0.000792	0.00472	CcSEcCtD
Bumetanide—Arthralgia—Ifosfamide—germ cell cancer	0.000792	0.00472	CcSEcCtD
Bumetanide—CA14—brain—germ cell cancer	0.000789	0.00349	CbGeAlD
Bumetanide—CA5B—endocrine gland—germ cell cancer	0.000772	0.00341	CbGeAlD
Bumetanide—Muscle spasms—Cisplatin—germ cell cancer	0.000771	0.0046	CcSEcCtD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000767	0.0114	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000767	0.0114	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000767	0.0114	CbGpPWpGaD
Bumetanide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000765	0.0113	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000764	0.0113	CbGpPWpGaD
Bumetanide—CA5B—head—germ cell cancer	0.000762	0.00337	CbGeAlD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000756	0.0112	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000756	0.0112	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000756	0.0112	CbGpPWpGaD
Bumetanide—Asthenia—Vinblastine—germ cell cancer	0.000755	0.0045	CcSEcCtD
Bumetanide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000753	0.0112	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000752	0.0111	CbGpPWpGaD
Bumetanide—SLCO1A2—medulla oblongata—germ cell cancer	0.00075	0.00332	CbGeAlD
Bumetanide—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000744	0.00443	CcSEcCtD
Bumetanide—CA5B—testis—germ cell cancer	0.000736	0.00326	CbGeAlD
Bumetanide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000734	0.00438	CcSEcCtD
Bumetanide—Diarrhoea—Vinblastine—germ cell cancer	0.00072	0.00429	CcSEcCtD
Bumetanide—Leukopenia—Cisplatin—germ cell cancer	0.000718	0.00428	CcSEcCtD
Bumetanide—Fatigue—Dactinomycin—germ cell cancer	0.000714	0.00426	CcSEcCtD
Bumetanide—SLC22A7—brain—germ cell cancer	0.000712	0.00315	CbGeAlD
Bumetanide—Hypotension—Ifosfamide—germ cell cancer	0.00071	0.00423	CcSEcCtD
Bumetanide—SLC12A1—brain—germ cell cancer	0.000709	0.00313	CbGeAlD
Bumetanide—Muscle spasms—Etoposide—germ cell cancer	0.000707	0.00421	CcSEcCtD
Bumetanide—Urticaria—Bleomycin—germ cell cancer	0.000706	0.00421	CcSEcCtD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000696	0.0103	CbGpPWpGaD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000696	0.0103	CbGpPWpGaD
Bumetanide—Dizziness—Vinblastine—germ cell cancer	0.000696	0.00415	CcSEcCtD
Bumetanide—CA4—pituitary gland—germ cell cancer	0.000688	0.00304	CbGeAlD
Bumetanide—SLC22A6—brain—germ cell cancer	0.000687	0.00304	CbGeAlD
Bumetanide—SLCO1A2—midbrain—germ cell cancer	0.000686	0.00303	CbGeAlD
Bumetanide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000678	0.00404	CcSEcCtD
Bumetanide—SLCO1A2—spinal cord—germ cell cancer	0.000669	0.00296	CbGeAlD
Bumetanide—Vomiting—Vinblastine—germ cell cancer	0.000669	0.00399	CcSEcCtD
Bumetanide—CA4—medulla oblongata—germ cell cancer	0.000664	0.00293	CbGeAlD
Bumetanide—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000663	0.00982	CbGpPWpGaD
Bumetanide—Vertigo—Etoposide—germ cell cancer	0.00066	0.00394	CcSEcCtD
Bumetanide—Headache—Vinblastine—germ cell cancer	0.000659	0.00393	CcSEcCtD
Bumetanide—PTGS2—trigeminal ganglion—germ cell cancer	0.000658	0.00291	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000658	0.00392	CcSEcCtD
Bumetanide—Leukopenia—Etoposide—germ cell cancer	0.000658	0.00392	CcSEcCtD
Bumetanide—Abdominal pain—Dactinomycin—germ cell cancer	0.000655	0.00391	CcSEcCtD
Bumetanide—Fatigue—Ifosfamide—germ cell cancer	0.000655	0.0039	CcSEcCtD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000652	0.00967	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000643	0.00952	CbGpPWpGaD
Bumetanide—Thrombocytopenia—Cisplatin—germ cell cancer	0.000641	0.00382	CcSEcCtD
Bumetanide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000638	0.00945	CbGpPWpGaD
Bumetanide—Asthenia—Bleomycin—germ cell cancer	0.000638	0.0038	CcSEcCtD
Bumetanide—PTGS2—embryo—germ cell cancer	0.000636	0.00281	CbGeAlD
Bumetanide—Hyperhidrosis—Cisplatin—germ cell cancer	0.000633	0.00377	CcSEcCtD
Bumetanide—Pruritus—Bleomycin—germ cell cancer	0.000629	0.00375	CcSEcCtD
Bumetanide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000629	0.00931	CbGpPWpGaD
Bumetanide—Chest pain—Etoposide—germ cell cancer	0.000626	0.00373	CcSEcCtD
Bumetanide—Nausea—Vinblastine—germ cell cancer	0.000625	0.00373	CcSEcCtD
Bumetanide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000621	0.0037	CcSEcCtD
Bumetanide—Pancreatitis—Methotrexate—germ cell cancer	0.000619	0.00369	CcSEcCtD
Bumetanide—CA12—brain—germ cell cancer	0.000616	0.00272	CbGeAlD
Bumetanide—CA4—adrenal gland—germ cell cancer	0.000614	0.00272	CbGeAlD
Bumetanide—Hypotension—Cisplatin—germ cell cancer	0.000612	0.00365	CcSEcCtD
Bumetanide—CA4—midbrain—germ cell cancer	0.000607	0.00268	CbGeAlD
Bumetanide—Abdominal discomfort—Methotrexate—germ cell cancer	0.000606	0.00361	CcSEcCtD
Bumetanide—Urticaria—Ifosfamide—germ cell cancer	0.000603	0.0036	CcSEcCtD
Bumetanide—SLCO1A2—endocrine gland—germ cell cancer	0.000602	0.00266	CbGeAlD
Bumetanide—Abdominal pain—Ifosfamide—germ cell cancer	0.0006	0.00358	CcSEcCtD
Bumetanide—Asthenia—Dactinomycin—germ cell cancer	0.000595	0.00354	CcSEcCtD
Bumetanide—SLCO1A2—head—germ cell cancer	0.000595	0.00263	CbGeAlD
Bumetanide—CA4—bone marrow—germ cell cancer	0.000594	0.00263	CbGeAlD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000593	0.00879	CbGpPWpGaD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000592	0.00877	CbGpPWpGaD
Bumetanide—CA4—spinal cord—germ cell cancer	0.000592	0.00262	CbGeAlD
Bumetanide—Thrombocytopenia—Etoposide—germ cell cancer	0.000587	0.0035	CcSEcCtD
Bumetanide—Hyperhidrosis—Etoposide—germ cell cancer	0.00058	0.00346	CcSEcCtD
Bumetanide—SLCO1A2—testis—germ cell cancer	0.000574	0.00254	CbGeAlD
Bumetanide—CA4—female gonad—germ cell cancer	0.000573	0.00253	CbGeAlD
Bumetanide—SLC22A8—head—germ cell cancer	0.000568	0.00251	CbGeAlD
Bumetanide—Diarrhoea—Dactinomycin—germ cell cancer	0.000567	0.00338	CcSEcCtD
Bumetanide—Vomiting—Bleomycin—germ cell cancer	0.000565	0.00337	CcSEcCtD
Bumetanide—Hypotension—Etoposide—germ cell cancer	0.00056	0.00334	CcSEcCtD
Bumetanide—Rash—Bleomycin—germ cell cancer	0.00056	0.00334	CcSEcCtD
Bumetanide—Dermatitis—Bleomycin—germ cell cancer	0.00056	0.00334	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000558	0.00333	CcSEcCtD
Bumetanide—Renal failure—Methotrexate—germ cell cancer	0.000554	0.0033	CcSEcCtD
Bumetanide—CA5B—brain—germ cell cancer	0.000552	0.00244	CbGeAlD
Bumetanide—Asthenia—Ifosfamide—germ cell cancer	0.000545	0.00325	CcSEcCtD
Bumetanide—Sweating—Methotrexate—germ cell cancer	0.00054	0.00322	CcSEcCtD
Bumetanide—Pruritus—Ifosfamide—germ cell cancer	0.000537	0.0032	CcSEcCtD
Bumetanide—CA5B—lymph node—germ cell cancer	0.000534	0.00236	CbGeAlD
Bumetanide—CA4—endocrine gland—germ cell cancer	0.000533	0.00236	CbGeAlD
Bumetanide—SLCO1A2—cerebellum—germ cell cancer	0.00053	0.00235	CbGeAlD
Bumetanide—Nausea—Bleomycin—germ cell cancer	0.000528	0.00315	CcSEcCtD
Bumetanide—Vomiting—Dactinomycin—germ cell cancer	0.000527	0.00314	CcSEcCtD
Bumetanide—CA4—head—germ cell cancer	0.000526	0.00233	CbGeAlD
Bumetanide—Rash—Dactinomycin—germ cell cancer	0.000523	0.00312	CcSEcCtD
Bumetanide—Diarrhoea—Ifosfamide—germ cell cancer	0.00052	0.0031	CcSEcCtD
Bumetanide—Fatigue—Etoposide—germ cell cancer	0.000517	0.00308	CcSEcCtD
Bumetanide—PTGS2—telencephalon—germ cell cancer	0.000517	0.00229	CbGeAlD
Bumetanide—CA4—testis—germ cell cancer	0.000508	0.00225	CbGeAlD
Bumetanide—Dizziness—Ifosfamide—germ cell cancer	0.000502	0.00299	CcSEcCtD
Bumetanide—PTGS2—skin of body—germ cell cancer	0.000493	0.00218	CbGeAlD
Bumetanide—Nausea—Dactinomycin—germ cell cancer	0.000492	0.00293	CcSEcCtD
Bumetanide—Gastrointestinal pain—Etoposide—germ cell cancer	0.00049	0.00292	CcSEcCtD
Bumetanide—Vomiting—Ifosfamide—germ cell cancer	0.000483	0.00288	CcSEcCtD
Bumetanide—Rash—Ifosfamide—germ cell cancer	0.000479	0.00285	CcSEcCtD
Bumetanide—Dermatitis—Ifosfamide—germ cell cancer	0.000478	0.00285	CcSEcCtD
Bumetanide—Erythema multiforme—Methotrexate—germ cell cancer	0.000478	0.00285	CcSEcCtD
Bumetanide—Urticaria—Etoposide—germ cell cancer	0.000476	0.00284	CcSEcCtD
Bumetanide—Abdominal pain—Etoposide—germ cell cancer	0.000474	0.00283	CcSEcCtD
Bumetanide—Asthenia—Cisplatin—germ cell cancer	0.00047	0.0028	CcSEcCtD
Bumetanide—CA4—cerebellum—germ cell cancer	0.000469	0.00208	CbGeAlD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000456	0.00675	CbGpPWpGaD
Bumetanide—Nausea—Ifosfamide—germ cell cancer	0.000451	0.00269	CcSEcCtD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000449	0.00665	CbGpPWpGaD
Bumetanide—Diarrhoea—Cisplatin—germ cell cancer	0.000448	0.00267	CcSEcCtD
Bumetanide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	0.000447	0.00663	CbGpPWpGaD
Bumetanide—SLCO1A2—brain—germ cell cancer	0.000431	0.00191	CbGeAlD
Bumetanide—Asthenia—Etoposide—germ cell cancer	0.00043	0.00257	CcSEcCtD
Bumetanide—PTGS2—uterus—germ cell cancer	0.000429	0.0019	CbGeAlD
Bumetanide—Pruritus—Etoposide—germ cell cancer	0.000424	0.00253	CcSEcCtD
Bumetanide—PTGS2—pituitary gland—germ cell cancer	0.000421	0.00186	CbGeAlD
Bumetanide—Vomiting—Cisplatin—germ cell cancer	0.000416	0.00248	CcSEcCtD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000413	0.00612	CbGpPWpGaD
Bumetanide—Rash—Cisplatin—germ cell cancer	0.000413	0.00246	CcSEcCtD
Bumetanide—Dermatitis—Cisplatin—germ cell cancer	0.000412	0.00246	CcSEcCtD
Bumetanide—SLC22A8—brain—germ cell cancer	0.000411	0.00182	CbGeAlD
Bumetanide—Diarrhoea—Etoposide—germ cell cancer	0.00041	0.00245	CcSEcCtD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000407	0.00603	CbGpPWpGaD
Bumetanide—PTGS2—medulla oblongata—germ cell cancer	0.000406	0.0018	CbGeAlD
Bumetanide—Dizziness—Etoposide—germ cell cancer	0.000397	0.00236	CcSEcCtD
Bumetanide—Vertigo—Methotrexate—germ cell cancer	0.000396	0.00236	CcSEcCtD
Bumetanide—Leukopenia—Methotrexate—germ cell cancer	0.000394	0.00235	CcSEcCtD
Bumetanide—Nausea—Cisplatin—germ cell cancer	0.000389	0.00232	CcSEcCtD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000388	0.00575	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000382	0.00566	CbGpPWpGaD
Bumetanide—Vomiting—Etoposide—germ cell cancer	0.000381	0.00227	CcSEcCtD
Bumetanide—CA4—brain—germ cell cancer	0.000381	0.00169	CbGeAlD
Bumetanide—Rash—Etoposide—germ cell cancer	0.000378	0.00225	CcSEcCtD
Bumetanide—Dermatitis—Etoposide—germ cell cancer	0.000378	0.00225	CcSEcCtD
Bumetanide—PTGS2—adrenal gland—germ cell cancer	0.000376	0.00166	CbGeAlD
Bumetanide—Headache—Etoposide—germ cell cancer	0.000376	0.00224	CcSEcCtD
Bumetanide—Arthralgia—Methotrexate—germ cell cancer	0.000375	0.00223	CcSEcCtD
Bumetanide—Chest pain—Methotrexate—germ cell cancer	0.000375	0.00223	CcSEcCtD
Bumetanide—PTGS2—midbrain—germ cell cancer	0.000371	0.00164	CbGeAlD
Bumetanide—CA4—lymph node—germ cell cancer	0.000368	0.00163	CbGeAlD
Bumetanide—PTGS2—bone marrow—germ cell cancer	0.000364	0.00161	CbGeAlD
Bumetanide—PTGS2—spinal cord—germ cell cancer	0.000362	0.0016	CbGeAlD
Bumetanide—Nausea—Etoposide—germ cell cancer	0.000356	0.00212	CcSEcCtD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000354	0.00524	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000354	0.00524	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000354	0.00524	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000354	0.00524	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000352	0.00522	CbGpPWpGaD
Bumetanide—Thrombocytopenia—Methotrexate—germ cell cancer	0.000352	0.0021	CcSEcCtD
Bumetanide—PTGS2—female gonad—germ cell cancer	0.000351	0.00155	CbGeAlD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000347	0.00515	CbGpPWpGaD
Bumetanide—Hyperhidrosis—Methotrexate—germ cell cancer	0.000347	0.00207	CcSEcCtD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000342	0.00507	CbGpPWpGaD
Bumetanide—Hypotension—Methotrexate—germ cell cancer	0.000336	0.002	CcSEcCtD
Bumetanide—PTGS2—endocrine gland—germ cell cancer	0.000326	0.00144	CbGeAlD
Bumetanide—PTGS2—head—germ cell cancer	0.000322	0.00142	CbGeAlD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000321	0.00476	CbGpPWpGaD
Bumetanide—SLC22A7—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000314	0.00465	CbGpPWpGaD
Bumetanide—Fatigue—Methotrexate—germ cell cancer	0.00031	0.00185	CcSEcCtD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000309	0.00457	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000304	0.0045	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000301	0.00446	CbGpPWpGaD
Bumetanide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000294	0.00175	CcSEcCtD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00029	0.0043	CbGpPWpGaD
Bumetanide—PTGS2—cerebellum—germ cell cancer	0.000287	0.00127	CbGeAlD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000286	0.00423	CbGpPWpGaD
Bumetanide—Urticaria—Methotrexate—germ cell cancer	0.000285	0.0017	CcSEcCtD
Bumetanide—Abdominal pain—Methotrexate—germ cell cancer	0.000284	0.00169	CcSEcCtD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00027	0.004	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000269	0.00399	CbGpPWpGaD
Bumetanide—Asthenia—Methotrexate—germ cell cancer	0.000258	0.00154	CcSEcCtD
Bumetanide—Pruritus—Methotrexate—germ cell cancer	0.000254	0.00152	CcSEcCtD
Bumetanide—Diarrhoea—Methotrexate—germ cell cancer	0.000246	0.00147	CcSEcCtD
Bumetanide—CA9—Cellular responses to stress—H2AFZ—germ cell cancer	0.000245	0.00363	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00024	0.00355	CbGpPWpGaD
Bumetanide—Dizziness—Methotrexate—germ cell cancer	0.000238	0.00142	CcSEcCtD
Bumetanide—PTGS2—C-MYB transcription factor network—H2AFZ—germ cell cancer	0.000236	0.0035	CbGpPWpGaD
Bumetanide—PTGS2—brain—germ cell cancer	0.000233	0.00103	CbGeAlD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000232	0.00343	CbGpPWpGaD
Bumetanide—Vomiting—Methotrexate—germ cell cancer	0.000228	0.00136	CcSEcCtD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000228	0.00338	CbGpPWpGaD
Bumetanide—Rash—Methotrexate—germ cell cancer	0.000227	0.00135	CcSEcCtD
Bumetanide—Dermatitis—Methotrexate—germ cell cancer	0.000226	0.00135	CcSEcCtD
Bumetanide—PTGS2—lymph node—germ cell cancer	0.000225	0.000997	CbGeAlD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000225	0.00334	CbGpPWpGaD
Bumetanide—Headache—Methotrexate—germ cell cancer	0.000225	0.00134	CcSEcCtD
Bumetanide—PTGS2—C-MYB transcription factor network—KITLG—germ cell cancer	0.000217	0.00322	CbGpPWpGaD
Bumetanide—Nausea—Methotrexate—germ cell cancer	0.000213	0.00127	CcSEcCtD
Bumetanide—CA14—Metabolism—SLC2A3—germ cell cancer	0.000212	0.00314	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.00021	0.00311	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.00021	0.00311	CbGpPWpGaD
Bumetanide—CA14—Metabolism—SLC22A3—germ cell cancer	0.000209	0.00309	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000207	0.00307	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—SLC2A3—germ cell cancer	0.000206	0.00306	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—SLC22A3—germ cell cancer	0.000203	0.00301	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SLC2A3—germ cell cancer	0.000193	0.00285	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—SLC2A3—germ cell cancer	0.000193	0.00285	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000191	0.00282	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SLC22A3—germ cell cancer	0.00019	0.00281	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—SLC22A3—germ cell cancer	0.00019	0.00281	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000179	0.00265	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SLC2A3—germ cell cancer	0.000179	0.00264	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000177	0.00262	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SLC22A3—germ cell cancer	0.000176	0.00261	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000174	0.00258	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CRABP1—germ cell cancer	0.00017	0.00252	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CRABP1—germ cell cancer	0.000166	0.00246	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.00016	0.00237	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000157	0.00232	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CRABP1—germ cell cancer	0.000155	0.00229	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CRABP1—germ cell cancer	0.000155	0.00229	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000154	0.00229	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SLC2A3—germ cell cancer	0.000149	0.00221	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—KIT—germ cell cancer	0.000148	0.00219	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000147	0.00218	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SLC22A3—germ cell cancer	0.000147	0.00218	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000145	0.00215	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CRABP1—germ cell cancer	0.000143	0.00212	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SLC2A3—germ cell cancer	0.000142	0.00211	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000142	0.00211	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SLC22A3—germ cell cancer	0.00014	0.00208	CbGpPWpGaD
Bumetanide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000135	0.002	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000134	0.00198	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000132	0.00196	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000132	0.00195	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CRABP1—germ cell cancer	0.00012	0.00178	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SLC2A3—germ cell cancer	0.000115	0.0017	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CRABP1—germ cell cancer	0.000114	0.00169	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SLC22A3—germ cell cancer	0.000113	0.00168	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000107	0.00158	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000104	0.00154	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—AVP—germ cell cancer	9.69e-05	0.00144	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CRABP1—germ cell cancer	9.24e-05	0.00137	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—MYC—germ cell cancer	8.15e-05	0.00121	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—AVP—germ cell cancer	8.14e-05	0.00121	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	8e-05	0.00118	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC2A3—germ cell cancer	7.34e-05	0.00109	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC22A3—germ cell cancer	7.23e-05	0.00107	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—AVP—germ cell cancer	7.23e-05	0.00107	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—TP53—germ cell cancer	6.95e-05	0.00103	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	6.8e-05	0.00101	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—HRAS—germ cell cancer	6.4e-05	0.000948	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MYC—germ cell cancer	6.21e-05	0.00092	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CRABP1—germ cell cancer	5.9e-05	0.000873	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC2A3—germ cell cancer	5.3e-05	0.000784	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TP53—germ cell cancer	5.1e-05	0.000756	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC2A3—germ cell cancer	4.43e-05	0.000657	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC22A3—germ cell cancer	4.37e-05	0.000647	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.22e-05	0.000626	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CRABP1—germ cell cancer	3.56e-05	0.000527	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.47e-05	0.000514	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGF4—germ cell cancer	3.04e-05	0.000451	CbGpPWpGaD
Bumetanide—PTGS2—Disease—H2AFZ—germ cell cancer	2.72e-05	0.000402	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KITLG—germ cell cancer	2.5e-05	0.00037	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGFR3—germ cell cancer	1.86e-05	0.000275	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KIT—germ cell cancer	1.7e-05	0.000253	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MYC—germ cell cancer	9.38e-06	0.000139	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HRAS—germ cell cancer	7.37e-06	0.000109	CbGpPWpGaD
